1 / 14

Circulating Tumor Cells Market Growth Prospect, Future Trend, Comprehensive

Circulating tumor cells obtained via liquid biopsies are safer, cheaper, and less invasive than other surgical biopsies as liquid biopsies are considered a valuable tool in cancer diagnosis, before and after the onset of disease. Though circulating tumor cells technology is still under research phase but used for the prognosis of several cancer forms including, breast, melanoma, lung, colon, pancreas, and glioblastoma.

priyanka1988
Télécharger la présentation

Circulating Tumor Cells Market Growth Prospect, Future Trend, Comprehensive

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Circulating Tumor Cells Market Market Size Worth $26.45 Billion By 2028 | CAGR: 13.4%

  2. Circulating Tumor Cells Market Size Worth $26.45 Billion By 2028 “According to Polaris Market Research report, Circulating Tumor Cells market is witnessing a major transformation and is projected to reach $26.45 Billion By 2028 registering a CAGR of 13.4% during the forecast period 2021 to 2028.” The global Circulating Tumor Cells market growth is driven by some of the key factors such as growing awareness among consumers, increasing investments by private-public organizations, and favorable government policies. Additionally, many prominent players present in the market are concentrating on the adoption of new technology and product launches to obtain a competitive edge, which in turn contributes to the Circulating Tumor Cells market growth. The regulatory agencies are also playing a key role as the major driving force for the market, by safeguarding the quality of product/service offerings as well as accelerating new approvals. Circulating Tumor Cells Market Report Scope: The study provides a comprehensive view of the Circulating Tumor Cells market by segmenting it based on Technology, Application, Product, Specimen and region. All the segments of the market have been thoroughly analyzed based on present and future trends. The research report has identified the key segments contributing most to the Circulating Tumor Cells market growth in terms of revenue along with other vital factors impacting the market dynamics. Further, the market analysis covered in the report also answers the imperative question for new entrants and existing players operating in the market. Browse Detailed Research Report On Circulating Tumor Cells Market Analysis: https://www.polarismarketresearch.com/industry-analysis/circulating-tumor-cells-market - 2 -

  3. Circulating Tumor Cells Market Size Worth $26.45 Billion By 2028 By Technology By Application By Product By Specimen By Region •Circulating Tumor Cells Detection & Enrichment Methods •Circulating Tumor Cells Direct Detection Methods •Circulating Tumor Cells Analysis •Clinical/ Liquid Biopsy •Research •Kits & Reagents •Blood Collection Tubes •Devices or Systems •Blood •Bone Marrow •Other Body Fluids •North America (U.S., Canada) •Europe (France, Germany, UK, Italy, Spain, Netherlands, Austria) •Asia Pacific (Japan, China, India, Malaysia, Indonesia, South Korea) •Latin America (Brazil, Mexico, Argentina) •Middle East & Africa (Saudi Arabia, UAE, Israel, South Africa) Impact Analysis of COVID-19 on Circulating Tumor Cells Market The global Circulating Tumor Cells market is anticipated to continue its growth amid the covid-19 pandemic. After giving insightful information on market behavior pre and post COVID-19 pandemic, the report also sheds light on the key strategic moves to overcome the adverse impact of COVID-19 on business and turn the positive impact into a lucrative opportunity. Regional Outlook The regional market of North America is witnessing a significant rise in the growth rate and is expected to account for the largest market share over the forecast period. The market is flourishing as a result of its increasing application scope and ample availability of vital resources. During the forecast period, the Asia Pacific region is estimated to garner the highest CAGR for the Circulating Tumor Cells market, owing to the presence of several leading local and international players operating in the regional market. Gain access to our latest research report that includes a detailed analysis of the COVID-19 pandemic influencing the Circulating Tumor Cells market in different regions and how market players devising effective strategies to mitigate the effect of the pandemic: - 3 -

  4. Circulating Tumor Cells Market Size Worth $26.45 Billion By 2028 https://www.polarismarketresearch.com/industry-analysis/circulating-tumor-cells-market/speak-to- analyst Competitive Landscape Leading companies holding significant market shares in the Circulating Tumor Cells market are analyzed considering their market shares, growth rates, market revenue, business strategies, and latest developments. Recent events for these major companies such as acquisitions, research initiatives, technological advancements, new solution/product launches, and geographical expansions considered in finalizing their position in the market. According to Polaris Market Research, the leading players with a noteworthy share in the Circulating Tumor Cells market include Greiner Bio-One; BioFluidica, QIAGEN; Bio-Techne Corporation; Rarecells Diagnostics, ScreenCell, Menarini Silicon Biosystems; Fluxion Biosciences, Sysmex Corporation; Miltenyi Biotec, and Biocept, Inc. Request for sample: https://www.polarismarketresearch.com/industry-analysis/circulating-tumor-cells- market/request-for-sample Table of Contents 1.Introduction 1.1.Report Description 1.1.1.Objectives of the Study 1.1.2.Market Scope 1.1.3.Assumptions 1.2.Stakeholders 2.Executive Summary 2.1.Market Highlights 3.Research Methodology 3.1.Overview 3.1.1.Data Mining 3.2.Data Sources 3.2.1.Primary Sources 3.2.2.Secondary Sources 4.Circulating Tumor Cells Market Insights 4.1.Circulating Tumor Cells – Industry snapshot - 4 -

  5. Circulating Tumor Cells Market Size Worth $26.45 Billion By 2028 4.2.Circulating Tumor Cells Market Dynamics 4.2.1.Drivers and Opportunities 4.2.1.1. Potential applications of tumor cells as biomarkers 4.2.1.2. High adoption in companion diagnostics 4.2.2.Restraints and Challenges 4.2.2.1. Presence of alternatives 4.3.Porter’s Five Forces Analysis 4.3.1.Bargaining Power of Suppliers (Moderate) 4.3.2.Threats of New Entrants: (Low) 4.3.3.Bargaining Power of Buyers (Moderate) 4.3.4.Threat of Substitute (Moderate) 4.3.5.Rivalry among existing firms (High) 4.4.PESTLE Analysis 4.5.Circulating Tumor Cells Market Industry trends 5.Circulating Tumor Cells Market Assessment by Technology 5.1.Key Findings 5.2.Introduction 5.2.1.Global Circulating Tumor Cells Market, By Technology, 2016 – 2028 (USD Million) 5.3.CTC Detection & Enrichment Methods 5.3.1.Global Circulating Tumor Cells Market, by CTC Detection & Enrichment Methods, by Region, 2016 - 2028 (USD Million) 5.3.2.Immunocapture (Label-based) 5.3.2.1. CTC Detection & Enrichment Methods, by Immunocapture (Label-based), 2016 - 2028 (USD Million) 5.3.3.Size-based Separation (Label-free) 5.3.3.1. CTC Detection & Enrichment Methods, by Size-based Separation (Label- free), 2016 - 2028 (USD Million) 5.3.4.Density-based Separation (Label-free) 5.3.4.1. CTC Detection & Enrichment Methods, by Density-based Separation (Label-free), 2016 - 2028 (USD Million) 5.3.5.Combined Methods (Label-free) 5.3.5.1. CTC Detection & Enrichment Methods, by Combined Methods (Label-free), 2016 - 2028 (USD Million) 5.4.CTC Direct Detection Methods 5.4.1.Global Circulating Tumor Cells Market, by CTC Direct Detection Methods, by Region, 2016 - 2028 (USD Million) 5.4.2.SERS 5.4.2.1. CTC Direct Detection Methods, by SERS, 2016 - 2028 (USD Million) 5.4.3.Microscopy 5.4.3.1. CTC Direct Detection Methods, by Microscopy, 2016 - 2028 (USD Million) 5.4.4.Others 5.4.4.1. CTC Direct Detection Methods, by Others, 2016 - 2028 (USD Million) - 5 -

  6. Circulating Tumor Cells Market Size Worth $26.45 Billion By 2028 5.5.CTC Analysis 5.5.1.Global Circulating Tumor Cells Market, by CTC Analysis, by Region, 2016 - 2028 (USD Million) 6.Global Circulating Tumor Cells Market, by Application 6.1.Key Findings 6.2.Introduction 6.2.1.Global Circulating Tumor Cells Market, By Application, 2016 – 2028 (USD Million) 6.3.Clinical/Liquid Biopsy 6.3.1.Global Circulating Tumor Cells Market, by Clinical/Liquid Biopsy, By Region, 2016 - 2028 (USD Million) 6.4.Research 6.4.1.Global Circulating Tumor Cells Market, by Research, by Region, 2016 - 2028 (USD Million) 7.Global Circulating Tumor Cells Market, by Product 7.1.Key Findings 7.2.Introduction 7.2.1.Global Circulating Tumor Cells Market, By Product, 2016 – 2028 (USD Million) 7.3.Kits & Reagents 7.3.1.Global Circulating Tumor Cells Market, by Kits & Reagents, By Region, 2016 - 2028 (USD Million) 7.4.Blood Collection Tubes 7.4.1.Global Circulating Tumor Cells Market, by Blood Collection Tubes, by Region, 2016 - 2028 (USD Million) 7.5.Devices or Systems 7.5.1.Global Circulating Tumor Cells Market, by Devices or Systems, by Region, 2016 - 2028 (USD Million) 8.Circulating Tumor Cells Market Assessment by Specimen 8.1.Key Findings 8.2.Introduction 8.2.1.Global Circulating Tumor Cells Market, By Specimen, 2016 – 2028 (USD Million) 8.3.Blood 8.3.1.Global Circulating Tumor Cells Market, by Blood, by Region, 2016 - 2028 (USD Million) 8.4.Bone Marrow 8.4.1.Global Circulating Tumor Cells Market, by Bone Marrow, by Region, 2016 - 2028 (USD Million) - 6 -

  7. Circulating Tumor Cells Market Size Worth $26.45 Billion By 2028 8.5.Other Body Fluids 8.5.1.Global Circulating Tumor Cells Market, by Other Body Fluids, by Region, 2016 - 2028 (USD Million) 9.Circulating Tumor Cells Market Assessment by Geography 9.1.Key findings 9.2.Introduction 9.2.1.Circulating Tumor Cells Market Assessment, By Geography, 2016 - 2028 (USD Million) 9.3.Circulating Tumor Cells Market – North America 9.3.1.North America: Circulating Tumor Cells Market, By Technology, 2016 - 2028 (USD Million) 9.3.2.North America: Circulating Tumor Cells Market, By Application, 2016 - 2028 (USD Million) 9.3.3.North America: Circulating Tumor Cells Market, By Product, 2016 - 2028 (USD Million) 9.3.4.North America: Circulating Tumor Cells Market, By Specimen, 2016 - 2028 (USD Million) 9.3.5.Circulating Tumor Cells Market – U.S. 9.3.5.1. U.S.: Circulating Tumor Cells Market, By Technology, 2016 - 2028 (USD Million) 9.3.5.2. U.S.: Circulating Tumor Cells Market, By Application, 2016 - 2028 (USD Million) 9.3.5.3. U.S.: Circulating Tumor Cells Market, By Product, 2016 - 2028 (USD Million) 9.3.5.4. U.S.: Circulating Tumor Cells Market, By Specimen, 2016 - 2028 (USD Million) 9.3.6.Circulating Tumor Cells Market – Canada 9.3.6.1. Canada: Circulating Tumor Cells Market, By Technology, 2016 - 2028 (USD Million) 9.3.6.2. Canada.: Circulating Tumor Cells Market, By Application, 2016 - 2028 (USD Million) 9.3.6.3. Canada: Circulating Tumor Cells Market, By Product, 2016 - 2028 (USD Million) 9.3.6.4. Canada: Circulating Tumor Cells Market, By Specimen, 2016 - 2028 (USD Million) 9.4.Circulating Tumor Cells Market – Europe 9.4.1.Europe: Circulating Tumor Cells Market, By Technology, 2016 - 2028 (USD Million) 9.4.2.Europe: Circulating Tumor Cells Market, By Application, 2016 - 2028 (USD Million) 9.4.3.Europe: Circulating Tumor Cells Market, By Product, 2016 - 2028 (USD Million) 9.4.4.Europe: Circulating Tumor Cells Market, By Specimen, 2016 - 2028 (USD Million) 9.4.5.Circulating Tumor Cells Market – UK - 7 -

  8. Circulating Tumor Cells Market Size Worth $26.45 Billion By 2028 9.4.5.1. UK: Circulating Tumor Cells Market, By Technology, 2016 - 2028 (USD Million) 9.4.5.2. UK: Circulating Tumor Cells Market, By Application, 2016 - 2028 (USD Million) 9.4.5.3. UK: Circulating Tumor Cells Market, By Product, 2016 - 2028 (USD Million) 9.4.5.4. UK: Circulating Tumor Cells Market, By Specimen, 2016 - 2028 (USD Million) 9.4.6.Circulating Tumor Cells Market – France 9.4.6.1. France: Circulating Tumor Cells Market, By Technology, 2016 - 2028 (USD Million) 9.4.6.2. France: Circulating Tumor Cells Market, By Application, 2016 - 2028 (USD Million) 9.4.6.3. France: Circulating Tumor Cells Market, By Product, 2016 - 2028 (USD Million) 9.4.6.4. France: Circulating Tumor Cells Market, By Specimen, 2016 - 2028 (USD Million) 9.4.7.Circulating Tumor Cells Market – Germany 9.4.7.1. Germany: Circulating Tumor Cells Market, By Technology, 2016 - 2028 (USD Million) 9.4.7.2. Germany: Circulating Tumor Cells Market, By Application, 2016 - 2028 (USD Million) 9.4.7.3. Germany: Circulating Tumor Cells Market, By Product, 2016 - 2028 (USD Million) 9.4.7.4. Germany: Circulating Tumor Cells Market, By Specimen, 2016 - 2028 (USD Million) 9.4.8.Circulating Tumor Cells Market – Italy 9.4.8.1. Italy: Circulating Tumor Cells Market, By Technology, 2016 - 2028 (USD Million) 9.4.8.2. Italy: Circulating Tumor Cells Market, By Application, 2016 - 2028 (USD Million) 9.4.8.3. Italy: Circulating Tumor Cells Market, By Product, 2016 - 2028 (USD Million) 9.4.8.4. Italy: Circulating Tumor Cells Market, By Specimen, 2016 - 2028 (USD Million) 9.4.9.Circulating Tumor Cells Market – Spain 9.4.9.1. Spain: Circulating Tumor Cells Market, By Technology, 2016 - 2028 (USD Million) 9.4.9.2. Spain: Circulating Tumor Cells Market, By Application, 2016 - 2028 (USD Million) 9.4.9.3. Spain: Circulating Tumor Cells Market, By Product, 2016 - 2028 (USD Million) 9.4.9.4. Spain: Circulating Tumor Cells Market, By Specimen, 2016 - 2028 (USD Million) 9.4.10.Circulating Tumor Cells Market – Netherlands - 8 -

  9. Circulating Tumor Cells Market Size Worth $26.45 Billion By 2028 9.4.10.1.Netherlands: Circulating Tumor Cells Market, By Technology, 2016 - 2028 (USD Million) 9.4.10.2.Netherlands: Circulating Tumor Cells Market, By Application, 2016 - 2028 (USD Million) 9.4.10.3.Netherlands: Circulating Tumor Cells Market, By Product, 2016 - 2028 (USD Million) 9.4.10.4.Netherlands: Circulating Tumor Cells Market, By Specimen, 2016 - 2028 (USD Million) 9.4.11.Circulating Tumor Cells Market – Austria 9.4.11.1.Austria: Circulating Tumor Cells Market, By Technology, 2016 - 2028 (USD Million) 9.4.11.2.Austria: Circulating Tumor Cells Market, By Application, 2016 - 2028 (USD Million) 9.4.11.3.Austria: Circulating Tumor Cells Market, By Product, 2016 - 2028 (USD Million) 9.4.11.4.Austria: Circulating Tumor Cells Market, By Specimen, 2016 - 2028 (USD Million) 9.5.Circulating Tumor Cells Market – Asia-Pacific 9.5.1.Asia Pacific: Circulating Tumor Cells Market, By Technology, 2016 - 2028 (USD Million) 9.5.2.Asia Pacific: Circulating Tumor Cells Market, By Application, 2016 - 2028 (USD Million) 9.5.3.Asia-pacific: Circulating Tumor Cells Market, By Product, 2016 - 2028 (USD Million) 9.5.4.Asia-pacific: Circulating Tumor Cells Market, By Specimen, 2016 - 2028 (USD Million) 9.5.5.Circulating Tumor Cells Market – China 9.5.5.1. China: Circulating Tumor Cells Market, By Technology, 2016 - 2028 (USD Million) 9.5.5.2. China: Circulating Tumor Cells Market, By Application, 2016 - 2028 (USD Million) 9.5.5.3. China: Circulating Tumor Cells Market, By Product, 2016 - 2028 (USD Million) 9.5.5.4. China: Circulating Tumor Cells Market, By Specimen, 2016 - 2028 (USD Million) 9.5.6.Circulating Tumor Cells Market – India 9.5.6.1. India: Circulating Tumor Cells Market, By Technology, 2016 - 2028 (USD Million) 9.5.6.2. India: Circulating Tumor Cells Market, By Application, 2016 - 2028 (USD Million) 9.5.6.3. India: Circulating Tumor Cells Market, By Product, 2016 - 2028 (USD Million) 9.5.6.4. India: Circulating Tumor Cells Market, By Specimen, 2016 - 2028 (USD Million) 9.5.7.Circulating Tumor Cells Market – Malaysia - 9 -

  10. Circulating Tumor Cells Market Size Worth $26.45 Billion By 2028 9.5.7.1. Malaysia: Circulating Tumor Cells Market, By Technology, 2016 - 2028 (USD Million) 9.5.7.2. Malaysia: Circulating Tumor Cells Market, By Application, 2016 - 2028 (USD Million) 9.5.7.3. Malaysia: Circulating Tumor Cells Market, By Product, 2016 - 2028 (USD Million) 9.5.7.4. Malaysia: Circulating Tumor Cells Market, By Specimen, 2016 - 2028 (USD Million) 9.5.8.Circulating Tumor Cells Market – Japan 9.5.8.1. Japan: Circulating Tumor Cells Market, By Technology, 2016 - 2028 (USD Million) 9.5.8.2. Japan: Circulating Tumor Cells Market, By Application, 2016 - 2028 (USD Million) 9.5.8.3. Japan: Circulating Tumor Cells Market, By Product, 2016 - 2028 (USD Million) 9.5.8.4. Japan: Circulating Tumor Cells Market, By Specimen, 2016 - 2028 (USD Million) 9.5.9.Circulating Tumor Cells Market – Indonesia 9.5.9.1. Indonesia: Circulating Tumor Cells Market, By Technology, 2016 - 2028 (USD Million) 9.5.9.2. Indonesia: Circulating Tumor Cells Market, By Application, 2016 - 2028 (USD Million) 9.5.9.3. Indonesia: Circulating Tumor Cells Market, By Product, 2016 - 2028 (USD Million) 9.5.9.4. Indonesia: Circulating Tumor Cells Market, By Specimen, 2016 - 2028 (USD Million) 9.5.10.Circulating Tumor Cells Market – South Korea 9.5.10.1.South Korea: Circulating Tumor Cells Market, By Technology, 2016 - 2028 (USD Million) 9.5.10.2.South Korea: Circulating Tumor Cells Market, By Application, 2016 - 2028 (USD Million) 9.5.10.3.South Korea: Circulating Tumor Cells Market, By Product, 2016 - 2028 (USD Million) 9.5.10.4.South Korea: Circulating Tumor Cells Market, By Specimen, 2016 - 2028 (USD Million) 9.6.Circulating Tumor Cells Market – Middle East & Africa 9.6.1.Middle East & Africa: Circulating Tumor Cells Market, By Technology, 2016 - 2028 (USD Million) 9.6.2.Middle East & Africa: Circulating Tumor Cells Market, By Application, 2016 - 2028 (USD Million) 9.6.3.Middle East & Africa: Circulating Tumor Cells Market, By Product, 2016 - 2028 (USD Million) 9.6.4.Middle East & Africa: Circulating Tumor Cells Market, By Specimen, 2016 - 2028 (USD Million) 9.6.5.Circulating Tumor Cells Market – Saudi Arabia - 10 -

  11. Circulating Tumor Cells Market Size Worth $26.45 Billion By 2028 9.6.5.1. Saudi Arabia: Circulating Tumor Cells Market, By Technology, 2016 - 2028 (USD Million) 9.6.5.2. Saudi Arabia: Circulating Tumor Cells Market, By Application, 2016 - 2028 (USD Million) 9.6.5.3. Saudi Arabia: Circulating Tumor Cells Market, By Product, 2016 - 2028 (USD Million) 9.6.5.4. Saudi Arabia: Circulating Tumor Cells Market, By Specimen, 2016 - 2028 (USD Million) 9.6.6.Circulating Tumor Cells Market – UAE 9.6.6.1. UAE: Circulating Tumor Cells Market, By Technology, 2016 - 2028 (USD Million) 9.6.6.2. UAE: Circulating Tumor Cells Market, By Application, 2016 - 2028 (USD Million) 9.6.6.3. UAE: Circulating Tumor Cells Market, By Product, 2016 - 2028 (USD Million) 9.6.6.4. UAE: Circulating Tumor Cells Market, By Specimen, 2016 - 2028 (USD Million) 9.6.7.Circulating Tumor Cells Market – Israel 9.6.7.1. Israel: Circulating Tumor Cells Market, By Technology, 2016 - 2028 (USD Million) 9.6.7.2. Israel: Circulating Tumor Cells Market, By Application, 2016 - 2028 (USD Million) 9.6.7.3. Israel: Circulating Tumor Cells Market, By Product, 2016 - 2028 (USD Million) 9.6.7.4. Israel: Circulating Tumor Cells Market, By Specimen, 2016 - 2028 (USD Million) 9.6.8.Circulating Tumor Cells Market – South Africa 9.6.8.1. South Africa: Circulating Tumor Cells Market, By Technology, 2016 - 2028 (USD Million) 9.6.8.2. South Africa: Circulating Tumor Cells Market, By Application, 2016 - 2028 (USD Million) 9.6.8.3. South Africa: Circulating Tumor Cells Market, By Product, 2016 - 2028 (USD Million) 9.6.8.4. South Africa: Circulating Tumor Cells Market, By Specimen, 2016 - 2028 (USD Million) 9.7.Circulating Tumor Cells Market – Latin America 9.7.1.Latin America: Circulating Tumor Cells Market, By Technology, 2016 - 2028 (USD Million) 9.7.2.Latin America: Circulating Tumor Cells Market, By Application, 2016 - 2028 (USD Million) 9.7.3.Latin America: Circulating Tumor Cells Market, By Product, 2016 - 2028 (USD Million) 9.7.4.Latin America: Circulating Tumor Cells Market, By Specimen, 2016 - 2028 (USD Million) 9.7.5.Circulating Tumor Cells Market – Mexico - 11 -

  12. Circulating Tumor Cells Market Size Worth $26.45 Billion By 2028 9.7.5.1. Mexico: Circulating Tumor Cells Market, By Technology, 2016 - 2028 (USD Million) 9.7.5.2. Mexico: Circulating Tumor Cells Market, By Application, 2016 - 2028 (USD Million) 9.7.5.3. Mexico: Circulating Tumor Cells Market, By Product, 2016 - 2028 (USD Million) 9.7.5.4. Mexico: Circulating Tumor Cells Market, By Specimen, 2016 - 2028 (USD Million) 9.7.6.Circulating Tumor Cells Market – Brazil 9.7.6.1. Brazil: Circulating Tumor Cells Market, By Technology, 2016 - 2028 (USD Million) 9.7.6.2. Brazil: Circulating Tumor Cells Market, By Application, 2016 - 2028 (USD Million) 9.7.6.3. Brazil: Circulating Tumor Cells Market, By Product, 2016 - 2028 (USD Million) 9.7.6.4. Brazil: Circulating Tumor Cells Market, By Specimen, 2016 - 2028 (USD Million) 9.7.7.Circulating Tumor Cells Market – Argentina 9.7.7.1. Argentina: Circulating Tumor Cells Market, By Technology, 2016 - 2028 (USD Million) 9.7.7.2. Argentina: Circulating Tumor Cells Market, By Application, 2016 - 2028 (USD Million) 9.7.7.3. Argentina: Circulating Tumor Cells Market, By Product, 2016 - 2028 (USD Million) 9.7.7.4. Argentina: Circulating Tumor Cells Market, By Specimen, 2016 - 2028 (USD Million) 10.Competitive Landscape 10.1. Expansion and Acquisition Analysis 10.1.1.Expansion 10.2. Partnerships/Collaborations/Agreements/Exhibitions 11.Company Profiles 11.1. Greiner Bio One 11.1.1.Company Overview 11.1.2.Financial Performance 11.1.3.Services Benchmarking 11.1.4.Recent Development 11.2. BioFluidica 11.2.1.Company Overview 11.2.2.Financial Performance 11.2.3.Services Benchmarking 11.2.4.Recent Development 11.3. QIAGEN - 12 -

  13. Circulating Tumor Cells Market Size Worth $26.45 Billion By 2028 11.3.1.Company Overview 11.3.2.Financial Performance 11.3.3.Services Benchmarking 11.3.4.Recent Development 11.4. Bio-Techne Corporation 11.4.1.Company Overview 11.4.2.Financial Performance 11.4.3.Services Benchmarking 11.4.4.Recent Development 11.5. Rarecells Diagnostics 11.5.1.Company Overview 11.5.2.Financial Performance 11.5.3.Services Benchmarking 11.5.4.Recent Development 11.6. ScreenCell 11.6.1.Company Overview 11.6.2.Financial Performance 11.6.3.Services Benchmarking 11.6.4.Recent Development 11.7. Menarini Silicon Biosystems 11.7.1.Company Overview 11.7.2.Financial Performance 11.7.3.Services Benchmarking 11.7.4.Recent Development 11.8. Fluxion Biosciences 11.8.1.Company Overview 11.8.2.Financial Performance 11.8.3.Services Benchmarking 11.8.4.Recent Development 11.9. Sysmex Corporation 11.9.1.Company Overview 11.9.2.Financial Performance 11.9.3.Services Benchmarking 11.9.4.Recent Development 11.10. Miltenyi Biotec 11.10.1. Company Overview 11.10.2. Financial Performance 11.10.3. Services Benchmarking 11.10.4. Recent Development Access Press Release on Circulating Tumor Cells Market: https://www.polarismarketresearch.com/press- releases/circulating-tumor-cells-market - 13 -

  14. Circulating Tumor Cells Market Size Worth $26.45 Billion By 2028 About Polaris Market Research Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises. We at Polaris are obliged to serve our diverse customer base present across the industries of healthcare, technology, semi-conductors, and chemicals among various other industries present around the world. We strive to provide our customers with updated information on innovative technologies, high growth markets, emerging business environments, and the latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced, and extremely qualified team of experts comprising SMEs, analysts, and consultants, we at Polaris endeavor to deliver value-added business solutions to our customers. E mail Id: sales@polarismarketresearch.com Web: www.polarismarketresearch.com Official Blog: http://polarismarketresearch.blogspot.com - 14 -

More Related